UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inflammation‐stratified augmentation of vortioxetine with celecoxib: Results from a double‐blind, randomized, placebo‐controlled trial in major depressive disorder

Journal of neurochemistry, 2024-09, Vol.168 (9), p.1817-1825

2024

Volltextzugriff (PDF)

Long-term characterisation of the relationship between change in depression severity and change in inflammatory markers following inflammation-stratified treatment with vortioxetine augmented with celecoxib or placebo

Brain, behavior, and immunity, 2025-01, Vol.123, p.43-56

2025

Volltextzugriff (PDF)

General intelligence and executive functioning are overlapping but separable at genetic and molecular pathway levels: An analytical review of existing GWAS findings

PloS one, 2022-10, Vol.17 (10), p.e0272368-e0272368

2022

Volltextzugriff (PDF)

Pharmacogenomic scores in psychiatry: systematic review of current evidence

Translational psychiatry, 2024-08, Vol.14 (1), p.322-16, Article 322

2024

Volltextzugriff (PDF)

Autoantibody profiles associated with clinical features in psychotic disorders

Translational psychiatry, 2021-09, Vol.11 (1), p.474-474, Article 474

2021

Volltextzugriff (PDF)

The use of clinical and biological characteristics to predict outcome following First Episode Psychosis

Australian & New Zealand Journal of Psychiatry, 2015-01, Vol.49 (1), p.24-35

2015

Volltextzugriff (PDF)

Trajectories of anxiety and health related quality of life during pregnancy

PloS one, 2017-07, Vol.12 (7), p.e0181149-e0181149

2017

Volltextzugriff (PDF)

Towards a Neurophenomenological Understanding of Self-Disorder in Schizophrenia Spectrum Disorders: A Systematic Review and Synthesis of Anatomical, Physiological, and Neurocognitive Findings

Brain sciences, 2023-05, Vol.13 (6), p.845

2023

Volltextzugriff (PDF)

A prospective registry analysis of psychosocial and metabolic health between women with and without metabolic syndrome after a complicated pregnancy

BMC women's health, 2022-11, Vol.22 (1), p.461-461, Article 461

2022

Volltextzugriff (PDF)

A gene co-expression module implicating the mitochondrial electron transport chain is associated with long-term response to lithium treatment in bipolar affective disorder

Translational psychiatry, 2018-09, Vol.8 (1), p.183-11, Article 183

2018

Volltextzugriff (PDF)

Cognitive and Functional Assessment of Psychosis Stratification Study (CoFAPSS): Rationale, Design, and Characteristics

Frontiers in psychiatry, 2018-12, Vol.9, p.662

2018

Volltextzugriff (PDF)

No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial

European neuropsychopharmacology, 2021-12, Vol.53, p.34-46

2021

Volltextzugriff (PDF)

Emotional Blunting in Depression in the PREDDICT Clinical Trial: Inflammation-Stratified Augmentation of Vortioxetine With Celecoxib

The international journal of neuropsychopharmacology, 2024-03, Vol.27 (3), p.1

2024

Volltextzugriff (PDF)

Demonstration of automated non-adherence and service disengagement risk monitoring with active follow-up for severe mental illness

Australian and New Zealand journal of psychiatry, 2021-10, Vol.55 (10), p.976-982

2021

Volltextzugriff (PDF)

Exploratory study of association between blood immune markers and cognitive symptom severity in major depressive disorder: Stratification by body mass index status

Brain, behavior, and immunity, 2020-08, Vol.88, p.242-251

2020

Volltextzugriff (PDF)

Corrigendum to ‘No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial’ [European Neuropsychopharmacology 53 (2021) 34–46]

European neuropsychopharmacology, 2022-11, Vol.64, p.61-62

2022

Volltextzugriff (PDF)

Targeted proteomic analysis of cognitive dysfunction in remitted major depressive disorder: Opportunities of multi-omics approaches towards predictive, preventive, and personalized psychiatry

Journal of proteomics, 2018-09, Vol.188, p.63-70

2018

Volltextzugriff (PDF)

Co-expression network analysis of peripheral blood transcriptome identifies dysregulated protein processing in endoplasmic reticulum and immune response in recurrent MDD in older adults

Journal of psychiatric research, 2018-12, Vol.107, p.19-27

2018

Volltextzugriff (PDF)

Downregulated transferrin receptor in the blood predicts recurrent MDD in the elderly cohort: A fuzzy forests approach

Journal of affective disorders, 2020-04, Vol.267, p.42-48

2020

Volltextzugriff (PDF)

Peripheral blood gene expression analysis implicates B lymphocyte proliferation and ribosomal S26 transcripts in cognitive dysfunction in people with remitted Major Depression

Journal of affective disorders, 2016-01, Vol.190, p.754-756

2016

Volltextzugriff (PDF)

Impact of a history of maternal depression and anxiety on asthma control during pregnancy

The Journal of asthma, 2017-08, Vol.54 (7), p.706-713

2017

Volltextzugriff (PDF)

Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3

Archives of general psychiatry, 2011-05, Vol.68 (5), p.477

2011

Volltextzugriff (PDF)

W66. PHARMACOGENOMIC DIVERSITY IN PSYCHIATRY: CHALLENGES AND OPPORTUNITIES IN AFRICA

European neuropsychopharmacology, 2024-10, Vol.87, p.136-137

2024

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Englisch
(83)
Deutsch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Inflammation‐stratified augmentation of vortioxetine with celecoxib: Results from a double‐blind, randomized, placebo‐controlled trial in major depressive disorder

Long-term characterisation of the relationship between change in depression severity and change in inflammatory markers following inflammation-stratified treatment with vortioxetine augmented with celecoxib or placebo

Genome-wide interaction study with major depression identifies novel variants associated with cognitive function

General intelligence and executive functioning are overlapping but separable at genetic and molecular pathway levels: An analytical review of existing GWAS findings

Pharmacogenomic scores in psychiatry: systematic review of current evidence

Autoantibody profiles associated with clinical features in psychotic disorders

The use of clinical and biological characteristics to predict outcome following First Episode Psychosis

Trajectories of anxiety and health related quality of life during pregnancy

Towards a Neurophenomenological Understanding of Self-Disorder in Schizophrenia Spectrum Disorders: A Systematic Review and Synthesis of Anatomical, Physiological, and Neurocognitive Findings

A prospective registry analysis of psychosocial and metabolic health between women with and without metabolic syndrome after a complicated pregnancy

A gene co-expression module implicating the mitochondrial electron transport chain is associated with long-term response to lithium treatment in bipolar affective disorder

Cognitive and Functional Assessment of Psychosis Stratification Study (CoFAPSS): Rationale, Design, and Characteristics

No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial

Emotional Blunting in Depression in the PREDDICT Clinical Trial: Inflammation-Stratified Augmentation of Vortioxetine With Celecoxib

Demonstration of automated non-adherence and service disengagement risk monitoring with active follow-up for severe mental illness

Exploratory study of association between blood immune markers and cognitive symptom severity in major depressive disorder: Stratification by body mass index status

Corrigendum to ‘No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial’ [European Neuropsychopharmacology 53 (2021) 34–46]

Targeted proteomic analysis of cognitive dysfunction in remitted major depressive disorder: Opportunities of multi-omics approaches towards predictive, preventive, and personalized psychiatry

Co-expression network analysis of peripheral blood transcriptome identifies dysregulated protein processing in endoplasmic reticulum and immune response in recurrent MDD in older adults

Downregulated transferrin receptor in the blood predicts recurrent MDD in the elderly cohort: A fuzzy forests approach

Peripheral blood gene expression analysis implicates B lymphocyte proliferation and ribosomal S26 transcripts in cognitive dysfunction in people with remitted Major Depression

Impact of a history of maternal depression and anxiety on asthma control during pregnancy

Validating cognitive screening in young people with first-episode psychosis: The CogScreen protocol

Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3

W66. PHARMACOGENOMIC DIVERSITY IN PSYCHIATRY: CHALLENGES AND OPPORTUNITIES IN AFRICA

Suchergebnisse filtern